Reviews
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
L. Bergmann, B. Berns, A. G. Dalgleish, M. von Euler, T. T. Hecht, G. L. Lappin, N. Reed, S. Palmeri, J. Smyth, S. Embacher-Aichorn, H. Zwierzina, and Biotherapy Development Association
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
Original Articles
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
G. D. Shah, N. D. Socci, J. S. Gold, J. D. Wolchok, R. D. Carvajal, K. S. Panageas, A. Viale, M. S. Brady, D. G. Coit, and P. B. Chapman